野村控股(NMR.US)告诉客户，在贸易紧张局势不断升级、金融市场陷入动荡之际，仍要保持投资。野 村以18亿美元收购麦格理在美国和欧洲的资产管理业务，揽入约1800亿美元的客户资产，其中约90%来 自美国。野村投资管理公司董事长Christopher Willcox在接受采访时说："我们不断告诉客户，在短期波 动中保持投资。所以，如果我们自己不表现出这些行为，我们就不会特别可信。" 自特朗普本月早些时候宣布全面征收关税以来，美国股票、债券和美元面临抛售压力。Willcox说，最 近的动荡并没有改变美国仍然是世界上最大的资产管理市场的事实。他表示，野村正寻求扩大业务规 模，以产生稳定的收入，并在国内零售业务、交易和投资银行业务之外实现多元化。 Willcox表示，野村至少考察了20个不同的潜在收购目标。未来，它可能会考虑进行一些附加交易，以 拓展现有平台。曾担任摩根大通资产管理业务主管的Willcox表示："显然，在如此剧烈的波动中进行这 笔交易具有挑战性，而且难度更大。但我认为，从两方面来看，我们都觉得这笔交易反映了当前的市场 状况。" Willcox指出，在过去的30到50年里，很多人都因为做空美国市场而赔 ...

The all-cash deal is expected to close by the end of this year, subject to regulatory approvals. Nomura said it has "identified global asset management as a key strategic growth priority for the organization," adding that this would increase the assets under management of its investment management division to $770 billion, up from the $590 billion currently. Signage for Nomura Holdings Inc. outside the company's Otemachi head office in Tokyo, Japan, on Wednesday, Oct. 30, 2024. Japanese investment bank and ...

金十数据4月21日讯，韩国4月前20天的贸易数据似乎是亚洲的一个坏兆头，野村证券分析师认为，远低 于预期的数据表明，韩国出口增长可能出现两位数的下滑。韩国出口的萎缩是广泛存在的，提前发货没 有如分析师预期般出现提振迹象。相反，分析师指出，尽管美国暂停了对等关税，但汽车和钢铁等行业 受关税冲击明显的行业仍受影响。韩国对美国的出口大幅下降，对日本、马来西亚和越南等主要贸易伙 伴的出口也出现负增长。总体而言，这些数据支持了野村证券有关亚洲出口增速将大幅下滑的观点。 野村证券：韩国贸易数据是矿井里的金丝雀 ...

Core Viewpoint - Nomura has revised its year-end forecast for the USD/JPY exchange rate from 140 to 137.50 due to concerns over U.S. tariffs imposed by President Trump and increasing worries about U.S. stagflation and asset credibility [1] Group 1 - Nomura's strategists Yujiro Goto and Jin Moteki are responsible for the report [1] - The adjustment in the forecast reflects a significant shift in market sentiment regarding the U.S. economy [1] - The concerns about U.S. tariffs and stagflation are key factors influencing the revised exchange rate prediction [1]

Core Viewpoint - The article highlights Nomura (NMR) as a strong value stock, supported by various valuation metrics indicating it is currently undervalued compared to its industry peers [4][5][6][7][8]. Valuation Metrics - Nomura has a P/E ratio of 7.69, significantly lower than the industry average of 12.57, indicating potential undervaluation [4]. - The P/B ratio for Nomura stands at 0.75, compared to the industry average of 1.96, further suggesting that the stock is undervalued [5]. - The P/S ratio for Nomura is 0.67, while the industry average is 1.99, reinforcing the notion of undervaluation [6]. - Nomura's P/CF ratio is 7.05, in contrast to the industry average of 14.14, indicating a favorable cash flow outlook relative to its peers [7]. Investment Outlook - Given the strength of its earnings outlook and the favorable valuation metrics, Nomura is positioned as one of the market's strongest value stocks [8].

Women's Day 在国际妇女节即将到来之际，野村集团祝所有女性朋友们节日快乐！ " 爱自己，是终身浪漫的开始 " 。 " 美好的清晨给自己做上一份营养丰富的早餐、温暖的午后翻阅一 本喜欢的书籍、闲暇的时间开启一段惬意的旅程 ……" ，女性关爱自己有很多方式，我们在一个个 爱自己的瞬间得到放松和快乐，倾听自己心里的声音，活出真实的自我。 本期《茶歇分享会》，我们邀请来自野村东方国际证券的金婷和野村新加坡有限公司的毛苏蓉，分 享她们各自对旅行和瑜伽的热爱和体会，一动一静，不同的 " 悦己 " 方式，都是在照顾自己的内心， 都是与内心的对话。 作为职场女性，在努力工作、追求社会价值的同时， 也要留出时间照顾自己的内心。 野村东方国际证券 金婷 Q1 您工作之余特别喜欢做什么？ 左右滑动，查看更多 Q2 请分享一下您近期旅游中有哪些难忘瞬间？ 金婷： 今年春节期间，我去了趟英国。在泰晤士河畔吹着晚风，听大本钟的钟声响起，感受这座 城市的浪漫。除了伦敦，我还去了约克。漫步在约克的古老街道，中世纪风格的建筑林立两旁， 那蜿蜒曲折的肉铺街，仿佛将我带回了久远的年代，街边特色小店琳琅满目，我淘到了不少精致 的复古小物件 ...

Core Insights - Nanalysis Scientific Corp. has launched its new 60 MHz Benchtop NMR spectrometer at the Pittcon Conference and Expo, showcasing advancements in portable NMR technology [1][2] - The new Nanalysis-60 instrument represents a significant improvement over the previous generation, targeting various industries including pharma, food, and mining [2][3] - The company continues to innovate within its magnetic resonance technology platform, with plans for future spectrometer products at different price points [3] Company Overview - Nanalysis operates two primary business segments: Scientific Equipment and Security Services, focusing on portable Nuclear Magnetic Resonance (NMR) spectrometers for industrial and laboratory markets [4][5] - The company has a strong innovation pipeline, having previously launched the NMReady-60™ and a 100 MHz device, which is the most advanced compact NMR device available [4] Market Applications - Nanalysis devices are utilized across various industries such as oil and gas, chemical, mining, pharma, and law enforcement, with a focus on expanding into new global markets [5] - The company has secured a five-year, $160 million contract for maintenance services of passenger screening equipment in Canadian airports, enhancing its security services segment [6][7] Product Features - The new Nanalysis-60 offers improved power, sensitivity, and automation features, including an autosampler and advanced software capabilities for enhanced NMR analysis [6]

Core Viewpoint - Nomura Holdings (NMR) is currently viewed as a better value opportunity compared to Bank of America (BAC) based on various valuation metrics and earnings outlook [1][7]. Valuation Metrics - NMR has a forward P/E ratio of 8.67, significantly lower than BAC's forward P/E of 11.93 [5]. - The PEG ratio for NMR is 0.30, indicating a more favorable valuation relative to its expected EPS growth compared to BAC's PEG ratio of 1.19 [5]. - NMR's P/B ratio stands at 0.81, while BAC's P/B ratio is higher at 1.24, suggesting that NMR is undervalued in terms of market value versus book value [6]. Earnings Outlook - NMR is experiencing an improving earnings outlook, which enhances its attractiveness in the Zacks Rank model, indicating a positive trend in earnings estimates [3][7]. - The Zacks Rank for NMR is 2 (Buy), while BAC holds a Zacks Rank of 3 (Hold), reflecting a stronger earnings estimate revision for NMR [3].

Market Overview - The three major U.S. indexes, Nasdaq Composite, Dow Jones Industrial Average, and S&P 500, experienced declines of 2.6%, 2.5%, and 1.9% respectively during a holiday-shortened trading week [1] - Concerns over persistent inflation, disappointing economic reports, and new tariff threats from President Trump contributed to investor anxiety [1] Federal Reserve and Economic Indicators - The Federal Reserve maintained key interest rates but expressed worries about rising inflation and the potential effects of Trump's fiscal, trade, and immigration policies [2] - The U.S. Consumer Sentiment Index dropped to a 15-month low of 64.7 in February, down from 71.7 in January [2] - The S&P Global's flash U.S. Composite PMI Output Index fell to a 17-month low of 50.4, down from 52.7 in January [2] Stock Performance and Recommendations - Nomura Holdings, Inc. (NMR) saw a share price increase of 12.3% since being upgraded to Zacks Rank 2 (Buy) on December 24 [3] - Corning Incorporated (GLW) returned 8.8% since its upgrade to Zacks Rank 2 on December 31 [4] - A hypothetical portfolio of Zacks Rank 1 (Strong Buy) stocks returned -3.48% in January 2025, compared to -0.60% for the S&P 500 index [4] Zacks Model Portfolio Performance - The Zacks Model Portfolio, consisting of Zacks Rank 1 stocks, has outperformed the S&P 500 index by nearly 13 percentage points since 1988, with an annualized average return of +23.9% [6] - The Zacks Focus List portfolio returned +3.13% in January 2025, outperforming the S&P 500 index's +2.79% [11] - The Focus List portfolio has produced an annualized return of +11.81% since 2004, compared to +10.48% for the S&P 500 index [12] Sector-Specific Stock Performance - AutoZone, Inc. (AZO) increased by 8.7% over the past 12 weeks, while Costco Wholesale Corporation (COST) rose by 7.4% [13] - The Coca-Cola Company (KO) returned 11.6% over the past 12 weeks, and Quest Diagnostics Incorporated (DGX) increased by 5.3% [16] - Primo Brands Corporation (PRMB) jumped 10.7% year-to-date, outperforming the S&P 500 index's 2.4% increase [19]

Core Viewpoint - Nomura Holdings (NMR) is currently viewed as a superior value opportunity compared to Bank of America (BAC) based on various valuation metrics [1][7]. Valuation Metrics - NMR has a forward P/E ratio of 9.03, while BAC has a forward P/E of 12.66 [5]. - NMR's PEG ratio is 0.31, indicating a more favorable valuation relative to its expected EPS growth rate compared to BAC's PEG ratio of 1.26 [5]. - NMR's P/B ratio stands at 0.84, contrasting with BAC's P/B of 1.32, suggesting that NMR is undervalued relative to its book value [6]. Earnings Outlook - Both NMR and BAC have a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies [3].